Products - Diabetes | Topic | NICE

Showing 7 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Type 1 diabetes in adults: diagnosis and management (update)
Status:
In development | In consultation
Programme:
NICE guideline
Consultation end date:
19 May 2021
Expected publication date:
21 July 2021
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
Status:
In development
Programme:
Diagnostics guidance
Expected publication date:
13 April 2022
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Brolucizumab for treating diabetic macular oedema [ID3902]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Faricimab for treating diabetic macular oedema [ID3899]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tirzepatide for treating type 2 diabetes ID3938
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC